Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab
Authors:
- 31 May 2009
- journal article
- laboratory investigation
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 53 (3) , 243-248
Abstract
Bevacizumab is a human monoclonal IgG1 antibody that blocks the action of vascular endothelial growth factor (VEGF). The purpose of this study was to determine the level of VEGF and pigment epithelium-derived factor (PEDF) in eyes with proliferative diabetic retinopathy (PDR) before and after an intravitreal injection of bevacizumab.Keywords
This publication has 32 references indexed in Scilit:
- Intravitreal Bevacizumab (Avastin) Injection for Neovascular GlaucomaJournal of Glaucoma, 2007
- REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENTRetina, 2006
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein OcclusionOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active siteProceedings of the National Academy of Sciences, 2004
- Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cellsBiochemical and Biophysical Research Communications, 2003
- Loss of the Antiangiogenic Pigment Epithelium-Derived Factor in Patients With Angiogenic Eye DiseaseDiabetes, 2001
- Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularizationJournal of Cellular Physiology, 2001
- Pigment Epithelium-Derived Factor: A Potent Inhibitor of AngiogenesisScience, 1999
- Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman PrimateArchives of Ophthalmology (1950), 1996
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994